BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29728791)

  • 1. Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis.
    Cai Z; Yin Y; Yin Y; Shen C; Wang J; Yin X; Chen Z; Zhou Y; Zhang B
    Gastric Cancer; 2018 Nov; 21(6):1031-1040. PubMed ID: 29728791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study.
    Kim IH; Park SS; Lee CM; Kim MC; Kwon IK; Min JS; Kim HI; Lee HH; Lee SI; Chae H
    Ann Surg Oncol; 2018 May; 25(5):1176-1183. PubMed ID: 29450755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network meta-analysis of the literature from the past 20 years.
    Cai Z; Yin Y; Shen C; Wang J; Yin X; Chen Z; Zhou Y; Zhang B
    Surg Oncol; 2018 Sep; 27(3):563-574. PubMed ID: 30217320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy.
    Wu B; Li T; Cai J; Xu Y; Zhao G
    BMC Cancer; 2014 Dec; 14():984. PubMed ID: 25526802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis.
    Kim SM; An JY; Lee J; Sohn TS; Kim S
    Ann Surg Oncol; 2018 Jun; 25(6):1616-1624. PubMed ID: 29569127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis.
    Zhu L; Liu J; Ma S
    Pathol Oncol Res; 2016 Oct; 22(4):853-61. PubMed ID: 27236591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study.
    Oh SE; An JY; Choi MG; Lee JH; Sohn TS; Bae JM
    Technol Cancer Res Treat; 2021; 20():15330338211039679. PubMed ID: 34605706
    [No Abstract]   [Full Text] [Related]  

  • 8. [CURRENT STATE OF ADJUVANT TREATMENT FOR GASTRIC CANCER AFTER RADICAL SURGERY WITH EXTENDED LYMPH NODE DISSECTION].
    Skoropad VY
    Vopr Onkol; 2015; 61(3):339-45. PubMed ID: 26242143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysis.
    Zhang Q; Qian Y; Yin Y
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1791-1804. PubMed ID: 34275019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer.
    Boda-Heggemann J; Weiss C; Schneider V; Hofheinz RD; Haneder S; Michaely H; Wertz H; Ronellenfitsch U; Hochhaus A; Wenz F; Lohr F
    Strahlenther Onkol; 2013 May; 189(5):417-23. PubMed ID: 23558673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.
    Tan C; Peng L; Zeng X; Li J; Wan X; Chen G; Yi L; Luo X; Zhao Z
    PLoS One; 2013; 8(12):e83396. PubMed ID: 24340099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New advances in the treatment of gastric cancer.
    Ilson DH
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-29-33. PubMed ID: 23570096
    [No Abstract]   [Full Text] [Related]  

  • 13. The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.
    Ter Veer E; Haj Mohammad N; van Valkenhoef G; Ngai LL; Mali RMA; Anderegg MC; van Oijen MGH; van Laarhoven HWM
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27576566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis.
    Duo-Ji MM; Ci-Ren BS; Long ZW; Zhang XH; Luo DL
    Oncotarget; 2017 Jun; 8(23):37896-37911. PubMed ID: 28099947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.
    Wang Y; Cheng X; Cui YH; Hou J; Ji Y; Sun YH; Shen ZB; Liu FL; Liu TS
    BMC Cancer; 2018 Jun; 18(1):702. PubMed ID: 29954358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
    Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
    J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis.
    Zhang D; Wu J; Wang K; Duan X; Liu S; Zhang B
    Medicine (Baltimore); 2018 Mar; 97(12):e0127. PubMed ID: 29561411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.
    Ter Veer E; Ngai LL; Valkenhoef GV; Mohammad NH; Anderegg MCJ; van Oijen MGH; van Laarhoven HWM
    Sci Rep; 2017 Aug; 7(1):7142. PubMed ID: 28769123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy.
    Cho JH; Lim JY; Cho JY
    PLoS One; 2017; 12(10):e0186362. PubMed ID: 29040299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.